Models for the Study of stroke

Handbook of Models for Human Aging

Volumn , Issue , 2006, Pages 947-960

  Arumugam, Thiruma V ^a   Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73649132331     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369391-4/50080-1     Document Type: Chapter

References (64)

1. N Andaluz, M. Zuccarello and K.R. Wagner (2002) Experimental animal models of intracerebral hemorrhage. Neurosurg Clin N Am 13 385-393.
2. S. Artavanis-Tsakonas, M.D. Rand and R.J. Lake (1999) Notch signaling: Cell fate control and signal integration in development. Science 284 770-776.
3. M. Arundine and M. Tymianski (2004) Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 61 657-668.
4. J.B. Bederson, L.H. Pitts and M. Tsuiji (1986) Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17 472-476.
5. J.S. Beech, J. Reckless, D.E. Mosedale, D.J. Grainger, S.C. Williams and D.K. Menon (2001) Neuroprotection in ischemia-reperfusion injury: An antiinflammatory approach using a novel broad-spectrum chemokine inhibitor. J Cereb Blood Flow Metab 21 683-689.
6. L. Belayev, I. Saul, K. Curbelo, R. Busto, A. Belayev, Y. Zhang, et al. (2003) Experimental intracerebral hemorrhage in the mouse: Histological, behavioral, and hemodynamic characterization of a double-injection model. Stroke 34 2221-2227.
7. B.W. Bottiger, P. Teschendorf, J.J. Krumnikl, P. Vogel, R. Galmbacher, B. Schmitz, et al. (1999) Global cerebral ischemia due to cardiocirculatory arrest in mice causes neuronal degeneration and early induction of transcription factor genes in the hippocampus. Brain Res Mol Brain Res 65 135-142.
8. T.S. Bowman, H.D. Sesso, J. Ma, T. Kurth, C.S. Kase, M.J. Stampfer, et al. (2003) Cholesterol and the risk of ischemic stroke. Stroke 34 2930-2934.
9. R.D. Brown, J.P. Whisnant, J.D. Sicks, W.M. O'Fallon and D.O. Wiebers (1996) Stroke incidence, prevalence, and survival: Secular trends in Rochester, Minnesota, through 1989. Stroke 27 373-380.
10. W. Clark, L. Gunion-Rinker, N. Lessov and K. Hazel (1998) Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke 29 2136-2140.
11. G.H. Danton and W.D. Dietrich (2004) The search for neuroprotective strategies in stroke. AJNR Am J Neuroradiol 25 181-194.
12. M. Davis, A.D. Mendelow, R.H. Perry, I.R. Chambers and O.F. James (1995) Experimental stroke and neuroprotection in the aging rat brain. Stroke 26 1072-1078.
13. V.L. Dawson and T.M. Dawson (1998) Nitric oxide in neurodegeneration. Prog Brain Res 118 215-229.
14. M.R. Del Bigio, H.J. Yan, R. Buist and J. Peeling (1996) Experimental intracerebral hemorrhage in rats: Magnetic resonance imaging and histopathological correlates. Stroke 27 2312-2319.
15. G.J. del Zoppo and J.M. Hallenbeck (2000) Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98 73-81.
16. M. Dichgans (2002) CADASIL: A monogenic condition causing stroke and subcortical vascular dementia. Cerebrovasc Dis 13 S37-S41.
17. R.M. Dijkhuizen and K. Nicolay (2003) Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab 23 1383-1402.
18. U. Dirnagl, I. Costantino and M.A. Moskowitz (1999) Pathobiology of ischemic stroke: An integrated view. Trends Neurosci 22 391-397.
19. J.R. Ewing, G.C. Brown, J.W. Gdowski, R. Simkins, S.R. Levine and K.M. Welch (1989) Stroke risk and age do not predict behavioral activation of brain blood flow. Ann Neurol 25 571-576.
20. J.L. Frey (2005) Recombinant tissue plasminogen activator (rtPA) for stroke. The perspective at 8 years. Neurologist 11 123-133.
21. K. Furuya, H. Takeda, S. Azhar, R.M. McCarron, Y. Chen, C.A. Ruetzler, et al. (2001) Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine antihuman intercellular adhesion molecule-1 antibody: A bedside-to-bench study. Stroke 32 2665-2674.
22. J.H. Garcia (1984) Experimental ischemic stroke: A review. Stroke 15 5-14.
23. E.D. Hall (1995) Inhibition of lipid peroxidation in central nervous system trauma and ischemia. J Neurol Sci 134 S79-S83.
24. H. Hara, R.M. Friedlander, V. Gagliardini, C. Ayata, K. Fink, Z. Huang, et al. (1997) Inhibition of interleukin 1 converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94 2007-2012.
25. D.C. Harrison and B.C. Bond (2005) Quantitative analysis of gene transcription in stroke models using real-time RT-PCR. Methods Mol Med 104 265-284.
26. A. Hassan and H.S. Markus (2000) Genetics and ischemic stroke. Brain 123 1784-1812.
27. M. Herrmann, M. Stern, F. Vollenweider and C. Nitsch (2004) Effect of inherent epileptic seizures on brain injury after transient cerebral ischemia in Mongolian gerbils. Exp Brain Res 154 176-182.
28. G. Howard, J.F. Toole, J. Frye-Pierson and L.C. Hinshelwood (1987) Factors influencing the survival of 451 transient ischemic attack patients. Stroke 18 552-557.
29. M. Ishikawa, J.H. Zhang, A. Nanda and D.N. Granger (2004) Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front Biosci 9 1339-1347.
30. X. Jiang, S. Namura and I. Nagata (2001) Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice. Neurosci Lett 305 41-44.
31. A. Joutel, D.D. Dodick, J.E. Parisi, M. Cecillon, E. Tournier-Lasserve and M.G. Bousser (2000) De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol 47 388-391.
32. P. Kermer, N. Klocker and M. Bahr (1999) Neuronal death after brain injury: Models, mechanisms, and therapeutic strategies in vivo. Cell Tissue Res 298 383-395.
33. K. Kitagawa, M. Matsumoto and G.M. Yang (1998) Cerebral ischemia after bilateral carotid artery occlusion and intraluminal suture in mice: Evaluation of the patence of posterior communicating artery. J Cereb Blood Flow Metab 18 570-579.
34. J.J. Legos, R.F. Tuma and F.C. Barone (2002) Pharmacological interventions for stroke: Failures and future. Expert Opin Investig Drugs 11 603-614.
35. J.J. Legos and F.C. Barone (2003) Update on pharmacological strategies for stroke: Prevention, acute intervention and regeneration. Curr Opin Investig Drugs 4 847-858.
36. D. Leys, D. Deplanque, C. Mounier-Vehier, M.A. Mackowiak-Cordoliani, C. Lucas and R. Bordet (2002) Stroke prevention: Management of modifiable vascular risk factors. J Neurol 249 507-517.
37. Y. Li, M. Chopp, J. Chen, L. Wang, S.C. Gautam, Y.X. Xu, et al. (2000) Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20 1311-1319.
38. P. Lipton (1999) Ischemic cell death in brain neurons. Physiol Rev 79 1431-1568.
39. S. Love (1999) Oxidative stress in brain ischemia. Brain Pathol 9 119-131.
40. G. Manjo and I. Joris (1995) Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 146 3-15.
41. B.N. Mankovsky and D. Ziegler (2004) Stroke in patients with diabetes mellitus. Diabetes Metab Res Rev 20 268-287.
42. H.S. Markus, J. Barley, R. Lunt, J.M. Blunt, S. Jeffery, N.D. Carter, et al. (1995) Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not for carotid atheroma. Stroke 26 1329-1333.
43. M.P. Mattson, S.L. Chan and W. Duan (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82 637-672.
44. M.P. Mattson, C. Culmsee and Z.F. Yu (2000) Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res 301 173-187.
45. M.P. Mattson (1997) Neuroprotective signal transduction: Relevance to stroke. Neurosci Biobehav Rev 21 193-206.
46. M.A. McAuley (1995) Rodent models of focal ischemia. Cerebrovasc Brain Metab Rev 7 153-180.
47. D.E. McBean and P.A. Kelly (1998) Rodent models of global cerebral ischemia: A comparison of two-vessel occlusion and four-vessel occlusion. Gen Pharmacol 30 431-434.
48. P. Mergenthaler, U. Dirnagl and A. Meisel (2004) Pathophysiology of stroke: Lessons from animal models. Metab Brain Dis 19 151-167.
49. R.W. Neumar (2000) Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 36 483-506.
50. N. Panahian, T. Yoshida, P.L. Huang, E.T. Hedley-Whyte, T. Dalkara, M.C. Fishman, et al. (1996) Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase. Neuroscience 72 343-354.
51. P. Rashid, J. Leonardi-Bee and P. Bath (2003) Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review. Stroke 34 2741-2748.
52. G.A. Rosenberg, S. Mun-Bryce, M. Wesley and M. Kornfeld (1990) Collagenase-induced intracerebral hemorrhage in rats. Stroke 21 801-807.
53. R.L. Sacco, R.T. Benson, D.E. Kargman, B. Boden-Albala, C. Tuck, I.F. Lin, et al. (2001) High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study. JAMA 285 2729-2735.
54. T.G. Shaw, K.F. Mortel, J.S. Meyer, R.L. Rogers, J. Hardenberg and M.M. Cutaia (1984) Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 34 855-862.
55. G. Stoll, S. Jander and M. Schroeter (1998) Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56 149-171.
56. J.H. Swan, M.C. Evans and B.S. Meldrum (1988) Long-term development of selective neuronal loss and the mechanism of protection by 2-amino-7-phosphonoheptanoate in a rat model of incomplete forebrain ischaemia. J Cereb Blood Flow Metab 8 64-78.
57. S.E. Tsirka (1997) Clinical implications of the involvement of tPA in neuronal cell death. J Mol Med 75 341-347.
58. R.S. Vasan, M.G. Larson, E.P. Leip, J.C. Evans, C.J. O'Donnell, W.B. Kannel, et al. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345 1291-1297.
59. B.D. Watson (1998) Animal models of photochemically induced brain ischemia and stroke. M.D. Ginsberg, J. Bogousslavsky (Eds) Cerebrovascular diseasepathophysiology, diagnosis and treatment Cambridge, MA: Blackwell Science 52-73.
60. I. Yonekura, N. Kawahara, H. Nakatomi, K. Furuya and T. Kirino (2004) A model of global cerebral ischemia in C57 BL/6 mice. J Cereb Blood Flow Metab 24 151-158.
61. Z.F. Yu, A.J. Bruce-Keller, Y. Goodman and M.P. Mattson (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53 613-625.
62. L. Zhang, Y. Andou, S. Masuda, A. Mitani and K. Kataoka (1993) Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci Lett 158 105-108.
63. L. Zhang, Z.G. Zhang, R.L. Zhang, M. Lu, M. Krams and M. Chopp (2003) Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 34 1790-1795.
64. Z. Zheng and M.A. Yenari (2004) Post-ischemic inflammation: Molecular mechanisms and therapeutic implications. Neurol Res 26 884-892.